Links

Address:
1 Sanqiang Road, Xinzhen, Fangshan District, Beijing, China
Zip code:102413  
Tel:+86-10-6935 8839
Mail:hta_imd@circ.com.cn

 

>
Historical development
HTA Co., Ltd. Obtained the Drug Registration Approval for the New Product
$info.title
Abstract:
HTA Co., Ltd. (hereinafter referred to as HTA) recently received the drug registration approval for "Sodium Iodide [I-131] Capsules for Therapeutic Use" issued by the National Medical Products Adminis
HTA Co., Ltd. Signed a Technology Co-Development Agreement with FutureChem Co., Ltd
$info.title
Abstract:
HTA Co., Ltd. (hereinafter referred to as “HTA”) signed a “Technology Co-Development Agreement” with FutureChem Co., Ltd (hereinafter referred to as “FutureChem”) on 9th September 2020.
HTA Will Launch the New Kr-85 Thickness Measurement Source on the Market
$info.title
Abstract:
The new domestic Kr-85 thickness measurement source developed by HTA Co., Ltd. (hereinafter referred to as “HTA”) will be put on the market soon.
HTA Co., Ltd. Visiting Indonesia to Develop International Market
$info.title
Abstract:
HTA President Cui Haiping leads a team to visit Indonesia, negotiating with a Indonesian company and other potential project investors on radiopharmaceutical bussiness.
China Isotope & Radiation Corporation Attending Annual Congress of the European Association of Nuclear Medicine
$info.title
Abstract:
China Isotope & Radiation Corporation has attended Annual Congress of the European Association of Nuclear Medicine.
Page up
1
2